ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment…

Overview of attention for article published in International Journal of Gynecological Cancer, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Readers on

mendeley: 82 Mendeley

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Article details
Title	ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Published in	International Journal of Gynecological Cancer, September 2021
DOI	10.1136/ijgc-2021-002933
Pubmed ID	34593565
Authors	Bradley J Monk, Robert L Coleman, Keiichi Fujiwara, Michelle K Wilson, Amit M Oza, Ana Oaknin, David M O’Malley, Domenica Lorusso, Shannon N Westin, Tamar Safra, Thomas J Herzog, Frederik Marmé, Ramez N Eskander, Kevin K Lin, Danny Shih, Sandra Goble, Nikolay Grechko, Stephanie Hume, Lara Maloney, Iain A McNeish, Rebecca S Kristeleit

View on publisher site Alert me about new mentions

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline

Activity

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Geographical breakdown
Country	Count	As %
Spain	1	100%

Demographic breakdown

Type
Type	Count	As %
Practitioners (doctors, other healthcare professionals)	1	100%

Mendeley demographics

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country	Count	As %
Unknown	82	100%

Demographic breakdown

Readers by professional status
Readers by professional status	Count	As %
Researcher	7	9%
Student > Bachelor	5	6%
Other	4	5%
Student > Ph. D. Student	4	5%
Student > Postgraduate	4	5%
Other	8	10%
Unknown	50	61%

Readers by discipline
Readers by discipline	Count	As %
Medicine and Dentistry	18	22%
Biochemistry, Genetics and Molecular Biology	4	5%
Nursing and Health Professions	3	4%
Pharmacology, Toxicology and Pharmaceutical Science	2	2%
Immunology and Microbiology	2	2%
Other	3	4%
Unknown	50	61%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2022.

All research outputs

#5,007,862

of 34,306,620 outputs

Outputs from International Journal of Gynecological Cancer

#502

of 4,238 outputs

Outputs of similar age

#84,016

of 466,292 outputs

Outputs of similar age from International Journal of Gynecological Cancer

#11

of 48 outputs

Altmetric has tracked 34,306,620 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 4,238 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 88% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 466,292 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.

We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.